Asia Pacific Gene Expression Analysis Market

Asia Pacific Gene Expression Analysis Market Size & Growth (2022 to 2027):

According to the report, the Size of the Gene Expression Analysis Market in the Asia Pacific is valued at USD 0.81 Billion in 2022 and is projected to grow at a CAGR of 12.7%, to reach USD 1.48 Billion by 2027 during the forecast period 2022 to 2027.

Each gene consists of a set of instructions for the synthesis of a particular protein. The process in which the protein is converted from information to an observable trait is called gene expression.

The study of the process in which the protein is produced is gene expression analysis. There are various methods and techniques to study gene expressions such as polymerase chain reaction and next-generation sequencing. Using these techniques the extent to which a gene is being expressed can be studied by measuring the amount of protein being synthesized.

Increasing R&D activities regarding the study of genomes, an increase in research on targeted drug development and availability of advanced technologies are the major factors driving the gene expression analysis market. The high cost of instruments required for gene expression profiling and lack of skilled technicians are the major factors restraining the market.

Asia Pacific Gene Expression Analysis Market has been segmented and sub-segmented into the following categories

• By Technology: DNA Microarray, PCR, NGS, SAGE, Northern Blotting.
• By Consumables: DNA Chips, Reagents.
• By Services: Gene Expression Profiling, Bioinformatics.
• By Application: Research, Drug Discovery, Diagnostics.
• By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

On the basis of Services, the market is segregated into gene expression profiling and bioinformatics solutions. The gene expression profiling services is again segregated into sequencing services and other services. Gene expression profiling holds the largest market share due to the rising number of gene expression analysis tests.

On the basis of Application, the Research holds the largest market share in this segment. Drug discovery and diagnostics are rapidly growing segments owing to the increasing focus on precision medicine.

On the basis of region, the Asia-Pacific region is projected to be the fastest-growing market due to government initiatives and increased agricultural research activities.

China is the major contributor in this market due to the collaborations with American companies to develop the domestic manufacturing of sequencing systems and to improve healthcare.

Top Companies dominating the Asia Pacific Gene Expression Analysis Market Profiled in the Report are PerkinElmer, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, GE Healthcare, QIAGEN N.V., Affymetrix, Life Technologies, Agilent Technologies, Roche, Illumina, Inc., Oxford Gene Technology, and Luminex Corporation.,